StockData
RVRCOTCPharmaceutical PreparationsFiscal year ends December 31

Revium Rx.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$1.43+0.00 (0.00%)

Close on Oct 16, 2026

Market cap
$86.84M
P/E (TTM)
–
Dividend yield
–

Revium Rx. revenue by segment

AnnualQuarterlyTTM

No segment breakdown reported

Revium Rx. does not break out revenue by segment, region or product in the tagged data of its filings for this period type.